Navigantis Raises $12M to Expand and Develop Interventional Robotic Platform for Neurovascular Procedures

Navigantis raises $12M in Series A Funding

Navigantis, a leading provider of interventional robotic platforms for neurovascular procedures, has secured $12M in Series A funding. With a focus on enhancing neurovascular care, Navigantis aims to revolutionize the healthcare industry by offering advanced robotic technologies.

Funding Amount: $12 million

Industry: Medical Equipment Manufacturing

Employee Count: 11-50

CEO: Mor Dayan (CEO Linkedin)

What Navigantis needs to buy: Navigantis is seeking partnerships with research institutions and medical device companies to advance their interventional robotic platform. Additionally, they require manufacturing and supply chain solutions to produce and distribute their robotic systems. Marketing and sales support services are also needed to promote and sell their innovative interventional robotic platform to healthcare providers and hospitals. Companies specializing in medical device manufacturing, research and development, and marketing and sales support are ideal partners for Navigantis.